Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP trial
Article Abstract:
Children with HIV Antibiotic Prophylaxis (CHAP) are a randomized trial comparing cotrimoxazole prophylaxis with placebo in HIV-infected Zambian children and the prognostic value of baseline characteristics is investigated by using Cox models. Malnutrition and hospitalizations for respiratory/bacterial infections have predicted mortality independent of immunosuppression, which has indicated that they capture HIV- and non-HIV-related mortality, whereas oral candidiasis is a proxy for immunosuppression.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
South Africa's "rollout" of highly active antiretroviral therapy: A critical assessment
Article Abstract:
South Africa's rollout of highly active antiretroviral therapy (HAART), which is found to be poor in comparison with other countries and in relation to the governments own targets, is discussed. The findings reveal that South Africa could have achieved a much higher HAART coverage than it has, as all the resources were made available to the Health Minister to facilitate a HAART rollout by the national Treasury, a significant portion of which was not used for the purpose.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Antiretroviral therapy and congenital abnormalities in infants born to HIV-1-infected women in the United Kingdom and Ireland, 1990 to 2003
Article Abstract:
Analysis was undertaken to explore the relation between antiretroviral therapy (ART) in pregnancy and birth defects in infants born to HIV-infected women in the United Kingdom and Ireland between 1990 and 2003. The Findings are reassuring but continued monitoring is essential in view of the increasing number of women on therapy at conception and the likely continuing diversity of drug regimens.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants
- Abstracts: Does exposure to antiretroviral therapy affect growth in the first 18 months of life in uninfected children born to HIV-infected women?
- Abstracts: Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial
- Abstracts: Predictors of nonadherence to single-dose nevirapine therapy for the prevention of mother-to-child HIV transmission
- Abstracts: Foes of mandatory maternal HIV testing fear guidelines will lead to reprisals. Parkinson disease guidelines aid diagnosis, management